BioAtla Newsroom

BioAtla Analyst Ratings

BenzingaNov 13 08:03 ET

H.C. Wainwright Downgrades BioAtla(BCAB.US) to Hold Rating

Moomoo NewsNov 13 06:31 ET

BioAtla Downgraded to Neutral From Buy at H.C. Wainwright

TipRanksNov 13 06:07 ET

JMP Securities Maintains BioAtla(BCAB.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsNov 13 01:32 ET

BioAtla: Strong Financials and Promising Clinical Progress Drive Buy Rating

TipRanksNov 13 00:48 ET

BTIG Maintains BioAtla(BCAB.US) With Buy Rating, Maintains Target Price $13

Moomoo NewsSep 24 07:33 ET

BioAtla Analyst Ratings

BenzingaSep 16 09:55 ET

JMP Securities Maintains BioAtla(BCAB.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsSep 16 00:31 ET

BTIG Initiates BioAtla(BCAB.US) With Buy Rating, Announces Target Price $13

Moomoo NewsAug 20 08:31 ET

Buy Rating for BioAtla: Promising Pipeline and Strategic Partnerships Fuel Optimistic Outlook

TipRanksAug 20 07:39 ET

Reni Benjamin's Buy Rating for BioAtla: Strong Pipeline and Financial Health Signal Upside Potential

TipRanksAug 13 00:32 ET

BioAtla (BCAB) Receives a Buy From J.P. Morgan

TipRanksJul 29 00:57 ET

JMP Securities Maintains BioAtla(BCAB.US) With Buy Rating, Maintains Target Price $5

Moomoo NewsJul 26 01:32 ET

Buy Rating for BioAtla: Promising Clinical Assets and Undervaluation Present Investment Opportunity

TipRanksJul 26 00:49 ET

Buy Rating Affirmed for BioAtla on Strong Clinical Data and Robust Financials

TipRanksJun 3 00:48 ET

BioAtla Analyst Ratings

BenzingaMay 23 12:10 ET

Buy Rating for BioAtla: Promising Clinical Data and Strong Financial Position Signal Upside Potential

TipRanksMay 23 00:41 ET

BioAtla Analyst Ratings

BenzingaMay 15 11:21 ET

Buy Rating Affirmed for BioAtla on Strong Clinical Data and Strategic Pipeline Progress

TipRanksMay 15 06:35 ET

Buy Rating Affirmed for BioAtla on Strong Clinical Pipeline and Financial Stability

TipRanksApr 10 19:12 ET